[
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-08-13\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often ",
    "url": "./specification.html",
    "section": "Core Specification",
    "keywords": "MS OR COLUMN MAY SHALL disease INFRINGE PATO HF cell type USE PURPOSE source name RFC SN ancestry category DIA TO OF PO INFORMATION organism part CLO XL collision energy SDRF spiked compound EFO IMPORTANT WARRANTY PATCH CELL disease stage MINOR developmental stage EXPRESS ISA biosample accession number DDA MAJOR PMCID biological replicate AC ENVO PS CV source name_ and _assay name ROW BTO sample EM EBI III BE MIAME FOR FDR DTT NT PSI PROTEOMICS VK ANY RIGHTS EW URL COULD MONDO proteomics data acquisition method WILL depletion BUT PRM TIP LIMITED MOD MERCHANTABILITY technical replicate CF CID TAB PMID cleavage agent details RECOMMENDED HCD SILAC FITNESS BRENDA ALL RAW RECOMMEND REQUIRED NOT SP CT THAT URI ZFA SHOULD OPTIONAL SRM pooled sample BMC MAGE LI HANCESTRO INCLUDING STANDARDS instrument DISCLAIMS README PEPTIDESEQ JA alkylation reagent PTM MANDATORY MHC INITIATIVE DJ MT QY CS CPTAC THE NCE characteristics PARTICULAR PRIDE organism IDF label II AS CN CL replicate individual DOID LC reduction reagent file your SWATH ... HTML MC data file TMT NOTE age WARRANTIES IS IAA HUPO PRIDE:0000659 dissociation method TA PP fraction identifier exclamation MUST HEREIN fractionation method SH ID mass REQUIRES MS:1001251 NCBI XML sex IMPLIED UBERON"
  },
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-08-13\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often ",
    "url": "./specification.html#sample-and-data-relationship-format-for-proteomics-sdrf-proteomics",
    "section": "Core Specification",
    "keywords": "MS OR COLUMN MAY SHALL disease INFRINGE PATO HF cell type USE PURPOSE RFC SN ancestry category DIA TO OF PO INFORMATION organism part CLO XL collision energy SDRF spiked compound EFO WARRANTY PATCH CELL disease stage MINOR EXPRESS ISA biosample accession number MAJOR DDA PMCID biological replicate AC ENVO PS CV ROW BTO EM EBI III BE MIAME FOR FDR DTT NT PSI PROTEOMICS VK ANY RIGHTS EW URL COULD MONDO proteomics data acquisition method WILL depletion BUT PRM MERCHANTABILITY LIMITED MOD technical replicate CF CID TAB PMID cleavage agent details RECOMMENDED HCD SILAC FITNESS BRENDA ALL RAW RECOMMEND REQUIRED NOT SP CT THAT URI ZFA SHOULD OPTIONAL SRM pooled sample BMC MAGE LI HANCESTRO INCLUDING STANDARDS instrument DISCLAIMS README PEPTIDESEQ JA alkylation reagent PTM MANDATORY MHC INITIATIVE DJ MT QY CS CPTAC THE NCE PARTICULAR PRIDE organism IDF label II AS CN CL individual DOID LC reduction reagent SWATH ... HTML MC data file TMT age WARRANTIES IS IAA HUPO PRIDE:0000659 dissociation method TA PP fraction identifier MUST HEREIN fractionation method SH mass REQUIRES MS:1001251 NCBI sex IMPLIED UBERON"
  },
  {
    "title": "Sample Metadata Conventions",
    "content": "Sample Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These conventions apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata conventions define standardized formats for common properties that apply across all organism types. This convention covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Convention.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSk",
    "url": "./conventions/sample-metadata.html",
    "section": "Sample Metadata Convention",
    "keywords": "MONDO:0005575 MONDO:0004946 MAY disease CL:0000057 PATO CL:0000084 cell type source name CL:0000787 ancestry category MONDO:0004989 PO PATO:0000383 organism part UBERON:0002097 UBERON:0001359 CL:0000236 SDRF CL:0000625 EFO IMPORTANT CSF developmental stage CL:0000815 MONDO:0004975 biological replicate UBERON:0001969 CL:0000813 CL:0000066 MONDO:0005180 MONDO:0005148 UBERON:0002113 disease model CL:0000232 URL MONDO MONDO:0005105 depletion TIP CL:0000788 UBERON:0001088 DSS CL:0000451 synthetic peptide UBERON:0002048 ALL CL:0000913 compound xenograft UBERON:0001155 CL:0000182 SHOULD PDX NSG CL:0000624 COVID UBERON:0002107 HANCESTRO MONDO:0005138 PTM UBERON:0000310 lib PATO:0000461 organism PATO:0000384 CL UBERON:0001977 individual DOID UBERON:0000955 MONDO:0008383 PATO:0001340 NK MONDO:0005301 CL:0000233 CL:0000623 UBERON:0000948 UBERON:0000178 NOTE age CL:0000540 MONDO:0100096 exclamation CL:0000235 MUST CL:0000898 enrichment process APP ID UBERON NCBI sex CL:0000576 CML"
  },
  {
    "title": "Sample Metadata Conventions",
    "content": "Sample Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These conventions apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata conventions define standardized formats for common properties that apply across all organism types. This convention covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Convention.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSk",
    "url": "./conventions/sample-metadata.html#sample-metadata-conventions",
    "section": "Sample Metadata Convention",
    "keywords": "MONDO:0005575 MONDO:0004946 MAY disease CL:0000057 PATO CL:0000084 cell type source name CL:0000787 ancestry category MONDO:0004989 PO organism part PATO:0000383 UBERON:0002097 UBERON:0001359 CL:0000236 SDRF CL:0000625 EFO CSF developmental stage CL:0000815 MONDO:0004975 biological replicate UBERON:0001969 CL:0000813 CL:0000066 MONDO:0005180 MONDO:0005148 UBERON:0002113 disease model CL:0000232 URL MONDO MONDO:0005105 depletion CL:0000788 UBERON:0001088 DSS CL:0000451 synthetic peptide UBERON:0002048 ALL CL:0000913 compound xenograft UBERON:0001155 CL:0000182 SHOULD PDX NSG CL:0000624 COVID UBERON:0002107 HANCESTRO MONDO:0005138 PTM UBERON:0000310 PATO:0000461 organism PATO:0000384 CL UBERON:0001977 individual DOID UBERON:0000955 MONDO:0008383 PATO:0001340 NK MONDO:0005301 CL:0000233 CL:0000623 UBERON:0000948 UBERON:0000178 age CL:0000540 MONDO:0100096 CL:0000235 MUST CL:0000898 enrichment process APP ID UBERON NCBI sex CL:0000576 CML"
  },
  {
    "title": "Human Sample Metadata Convention",
    "content": "Human Sample Metadata Convention\n\nStatus of this Convention\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These conventions apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This convention defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata conventions (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Conventions.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g",
    "url": "./conventions/human-metadata.html",
    "section": "Human Metadata Convention",
    "keywords": "NCIT:C28079 disease AJCC alcohol consumption NCIT:C53554 ACE ancestry category HANCESTRO:0010 ethnicity organism part IV pre-existing condition NCIT:C68804 CHEBI:41774 SDRF MONDO:0002050 NCIT:C16358 PD EFO IMPORTANT disease stage sampling time point MONDO:0011122 NCIT:C65108 medication history PR TNM staging NCIT:C14168 HANCESTRO:0005 breast cancer subtype III smoking status MONDO:0005148 NCIT:C53555 height MONDO GDPR NCIT:C65107 HANCESTRO:0006 NCIT:C28076 NCIT:C14167 NCIT:C18206 NCIT:C28077 NCIT:C15313 NCIT:C81327 BMI compound body mass index MONDO:0005300 NCIT:C15632 NCIT:C4870 MONDO:0005044 ER NCI NCIT:C71732 UO NCIT:C15262 tumor grade pregnancy status MONDO:0004995 NCIT:C81328 NCIT:C14174 CHEBI:28748 secondary condition NCIT:C14169 HANCESTRO NCIT:C28078 NCIT menopausal status NCIT:C62723 treatment response CHEBI:6801 CHEBI:27899 NCIT:C27966 HIPAA MONDO:0004979 NCIT:C27971 organism weight TNM NCIT:C65106 II NCIT:C18058 gestational age individual PREFERRED HANCESTRO:0009 NCIT:C15445 Ann Arbor stage NCIT:C28054 treatment status NOTE age NCIT:C53553 prior treatment NCIT:C27970 Dukes stage exclamation treatment NCIT:C15329 time post treatment ID NCIT:C18213 diet dose sex NCIT:C53556"
  },
  {
    "title": "Human Sample Metadata Convention",
    "content": "Human Sample Metadata Convention\n\nStatus of this Convention\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These conventions apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This convention defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata conventions (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Conventions.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g",
    "url": "./conventions/human-metadata.html#human-sample-metadata-convention",
    "section": "Human Metadata Convention",
    "keywords": "NCIT:C28079 disease AJCC alcohol consumption NCIT:C53554 ACE ancestry category HANCESTRO:0010 ethnicity organism part IV pre-existing condition NCIT:C68804 CHEBI:41774 SDRF MONDO:0002050 NCIT:C16358 PD EFO disease stage sampling time point MONDO:0011122 NCIT:C65108 medication history PR TNM staging NCIT:C14168 HANCESTRO:0005 breast cancer subtype III smoking status MONDO:0005148 NCIT:C53555 height MONDO GDPR NCIT:C65107 HANCESTRO:0006 NCIT:C28076 NCIT:C14167 NCIT:C18206 NCIT:C28077 NCIT:C15313 NCIT:C81327 BMI compound body mass index MONDO:0005300 NCIT:C15632 NCIT:C4870 MONDO:0005044 ER NCI NCIT:C71732 UO NCIT:C15262 tumor grade pregnancy status MONDO:0004995 NCIT:C81328 NCIT:C14174 CHEBI:28748 secondary condition NCIT:C14169 HANCESTRO NCIT:C28078 NCIT menopausal status NCIT:C62723 treatment response CHEBI:6801 CHEBI:27899 NCIT:C27966 HIPAA MONDO:0004979 NCIT:C27971 organism weight TNM NCIT:C65106 II NCIT:C18058 gestational age individual PREFERRED HANCESTRO:0009 NCIT:C15445 Ann Arbor stage NCIT:C28054 treatment status age NCIT:C53553 prior treatment NCIT:C27970 Dukes stage treatment NCIT:C15329 time post treatment ID NCIT:C18213 diet dose sex NCIT:C53556"
  },
  {
    "title": "Data File Metadata Conventions",
    "content": "Data File Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These conventions define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata conventions define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This convention covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata conventions (organism, age, sex, disease), see Sample Metadata Conventions.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\ns",
    "url": "./conventions/data-file-metadata.html",
    "section": "Data File Metadata Convention",
    "keywords": "MS label RAW MS:1001303 REQUIRED sample TOF UNIMOD:4 fragment mass tolerance FTP KR HF UNIMOD:21 LTQ fraction precursor mass tolerance MS1 scan range UNIMOD:737 MS:1001917 URI SHOULD MS:1001309 SRM NT PSI ST MSD data file DIA RPPA proteomexchange accession number TMT URL SCIEX NOTE proteomics data acquisition method MM XL SDRF instrument PRM MGF UNIMOD IMPORTANT TIP MOD MS:1001306 TA PP fraction identifier technical replicate CF UNIMOD:35 exclamation MUST cleavage agent details RECOMMENDED TS MRM scan window upper limit ID SILAC ELISA DDA MT CS MS:1001251 MS:1001313 UNIMOD:1 AC scan window lower limit file uri MS2 analyzer type modification parameters PRIDE PRIDE:0000663"
  },
  {
    "title": "Data File Metadata Conventions",
    "content": "Data File Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These conventions define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata conventions define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This convention covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata conventions (organism, age, sex, disease), see Sample Metadata Conventions.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\ns",
    "url": "./conventions/data-file-metadata.html#data-file-metadata-conventions",
    "section": "Data File Metadata Convention",
    "keywords": "MS label RAW MS:1001303 REQUIRED TOF UNIMOD:4 fragment mass tolerance FTP KR HF UNIMOD:21 LTQ precursor mass tolerance MS1 scan range UNIMOD:737 MS:1001917 URI SHOULD MS:1001309 SRM NT PSI ST MSD data file DIA RPPA proteomexchange accession number TMT URL SCIEX proteomics data acquisition method MM XL SDRF instrument PRM MGF UNIMOD MS:1001306 modification parameters MOD technical replicate TA PP fraction identifier CF UNIMOD:35 MUST cleavage agent details RECOMMENDED TS MRM scan window upper limit ID SILAC ELISA DDA MT CS MS:1001251 MS:1001313 UNIMOD:1 AC scan window lower limit file uri MS2 analyzer type PRIDE PRIDE:0000663"
  }
]